Tarveda Therapeutics
AcquiredWatertown, United States · $68.0M raised
- Headquarters
- Watertown, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Total Funding
- $68.0M
- Last Round
- $30.0M Series DFeb 2017
- Rounds
- 2
About
Tarveda Therapeutics is a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin® miniature drug conjugates, for the treatment of patients with various solid tumor malignancies. Tarveda's Pentarin® miniature drug conjugates are designed to deeply penetrate solid tumors, selectively bind to the desired tumor targets and accumulate their anti-cancer payloads directly in tumor cells.
Summary
Tarveda Therapeutics is a Biotech company based in Watertown, United States. It has raised $68.0M in total across 2 rounds, most recently a $30.0M Series D round in Feb 2017. Investors include Novo Holdings A/S, Versant Ventures and New Enterprise Associates.
Funding History
Feb 2017
Sign up to see all 2 rounds
Series C through Series D — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tarveda-therapeutics"><img src="https://indexed.vc/api/badge/company/tarveda-therapeutics" alt="Tarveda Therapeutics on Indexed.vc" width="260" height="76" /></a>